Hematology; leukemia, lymphoma, multiple myeloma, and the like; circulatory system, lymphatic system, and bone marrow-related diseases. A large proportion of hematologic diseases are a serious threat to human life. A professional teamwork and experience are necessary for the treatment of these diseases. Hematology is one of the areas where very important developments have been introduced in recent years, where clinical investigations have been made the most and treatment possibilities have increased in diseases. The rate of successful treatment of hematological cancers is increasing rapidly.
What are the Symptoms of Hematologic Diseases?
Rapid fatigue, palpitation, frequent infection, bleeding resulting from simple trauma, unstoppable bleeding, painless swelling in the neck, under the armpit or in the groin, and painful edema all over the knee or under the knee are the main symptoms observed in blood diseases.
What are the methods used to diagnose hematologic diseases?
Analysis of hemoglobin subtypes by electrophoresis, examination of blood under microscope (peripheral spread), examination of bone marrow (bone marrow aspiration and biopsy), iron, vitamin B12 and folic acid required for blood production (blood count), measurement of blood cells and hemoglobin assay of blood levels of blood clotting factors, tests of blood cell function and lifespan, examination of proteins produced by immune system cells, analysis of chromosomes and other building blocks of blood cells or bone marrow cells producing them and radiological examinations are the most frequently needed tests.
What is Bone Marrow Transplant?
Bone marrow transplantation is the process of delivering a bone marrow from a healthy donor to the recipient (patient) by means of a vein. Nowadays, contemporary chemotherapy regimens and treatment of leukemia children can be treated with 90% success in our country as well as in Europe and America according to risk groups. Our hospital has also achieved success rates in developed countries. For this reason, transplantation is considered appropriate for patients with leukemia who have an early recurrence or very high risk of disease. Transfusions are performed according to criteria determined by international standards for other types of leukemia and disease. A second transplant may be needed in cases where the bone marrow/stem cell fails to engage in transplantation or has failed transplantation for reasons such as rejection. In today's information light, there is no problem in giving the same donor more than one bone marrow/stem cell. In our hospital, bone marrow transplantation for both pediatric and adult patients has been done successfully.